Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
accelerated approval
Pharma
ASCO: Pfizer's Braftovi combo slashes death risk in rare cancer
Pfizer's Braftovi, combined with Eli Lilly's Erbitux and chemo, won an accelerated approval last year through the FDA's Project FrontRunner.
Zoey Becker
May 30, 2025 8:00am
Fierce Biotech
Stealth CEO questions FDA rejection of rare disease drug
May 29, 2025 2:27pm
AbbVie's ADC bet pays off with FDA nod for Emrelis
May 14, 2025 3:39pm
CBER chief Peter Marks resigns from FDA
Mar 31, 2025 10:50am
OIG says FDA accelerated approval program needs adjustments
Jan 16, 2025 3:45pm
FDA looks to clarify follow-up testing mandate for speedy nods
Jan 6, 2025 3:36pm
